Integrated oligonucleotide PEGylation services supporting siRNA, ASO, PNA, and PMO programs — with defined site control (3′/5′/internal), rational PEG architecture selection, validated conjugation chemistries, and CMC-aligned purification and analytics from discovery through preclinical scale.
PEGylation is the controlled covalent attachment of poly(ethylene glycol) (PEG) to an oligonucleotide to modulate physicochemical behavior, steric presentation, and conjugation modularity. PEG architecture and placement directly influence solubility, analytical resolution, conjugation efficiency, and downstream developability.
PEG selection is usually driven by (1) the intended function (solubility vs spacer vs shielding vs size tuning), (2) the conjugation handle/chemistry (amine, thiol, azide/alkyne), and (3) the PEG architecture (linear, dPEG, branched, multi-arm).
We support solid-phase incorporation (PEG/dPEG phosphoramidites, PEG supports) and post-synthetic conjugation (NHS–amine, maleimide–thiol, click chemistry, carbonyl ligations) with defined site control and analytics.
Quick facts
The best PEG linker is the smallest/cleanest structure that achieves your design goal and maintains activity.
Defined spacers
Linear PEG range
Core levers for PEGylated oligo design, developability, and scalable CMC execution.
Pick PEG length/architecture based on the minimum needed for solubility, spacing, or shielding.
Use NHS–amine, maleimide–thiol, or SPAAC click for robust and selective coupling workflows.
Resolve unconjugated/partial species and confirm identity with LC-MS and orthogonal chromatography.
Solid-phase synthesis: incorporate PEG/dPEG via phosphoramidites or PEG-functionalized supports for strict site control.
Post-synthetic conjugation: react a functionalized oligo (5′-amine, 5′-thiol, azide, etc.) with an activated PEG reagent for modular workflows.
PEG linkers are strategically selected to optimize performance, manufacturability, and analytical control of oligonucleotide conjugates. Their use extends beyond solubility enhancement to include steric modulation, modular assembly, and hydrodynamic tuning.
PEG increases hydrophilicity and can rescue insoluble or aggregation-prone conjugates (e.g., dyes, hydrophobic ligands).
PEG spacers can preserve binding/hybridization by separating bulky payloads from the oligo functional region.
PEG can decrease nonspecific adsorption to plastics/surfaces and reduce unwanted protein interactions.
Longer or branched PEGs can increase size and steric shielding; evaluate any uptake/penetration tradeoffs.
Azide/DBCO and other orthogonal handles simplify payload swapping and library-style conjugate screening.
Monodisperse dPEG spacers provide defined mass/length and simplify LC-MS interpretation.
General-purpose architecture for solubility enhancement and steric spacing across a broad molecular weight range.
Primary use case: broad applicability across conjugate formats.
Defined length (dPEG4/8/12/24…). Cleaner analytics and consistent spacer performance.
Primary use case: LC-MS clarity.
More steric shielding per MW than linear PEG; useful when long linear PEG is undesirable.
Primary use case: increased shielding.
Multivalency for surfaces, hydrogels, nanoparticles; can increase complexity of characterization.
Primary use case: materials and networks.
Redox-cleavable (disulfide) or other cleavables when controlled release is desired.
Primary use case: triggered release designs.
Two different end groups (e.g., NHS–PEG–maleimide) to bridge oligo and payload chemistries.
Primary use case: modular assembly
Spacer-only: dPEG4–dPEG12 (minimal size impact). Solubility + spacing: linear PEG 1–5 kDa. Size/steric tuning: PEG 10–20 kDa or branched PEG (application-dependent).
Linker choice and placement influence conjugation efficiency, purification behavior, stability, and biological performance. We support PEG/dPEG installation at the 3′ end, 5′ end, or internal positions depending on modality and design intent.
Diagram showing how Spacer 18 (hexaethylene glycol) can be incorporated at the 5′ end, internally, or at the 3′ end of an oligonucleotide.
Select a site that preserves function: avoid steric blocking of aptamer binding regions or duplex recognition elements. Internal placement is available when both termini must remain free.
Frequently implemented: 5′ or 3′ PEGylation
Stable linkers maintain conjugate integrity for distribution studies and handling; cleavable linkers enable controlled release in triggered environments.
Selection should align with program objectives.
Amine (e.g., 5′ amino-modifier) → NHS-PEG coupling. Thiol (e.g., 5′ thiol-modifier) → maleimide-PEG or disulfide exchange. Azide/Alkyne → click chemistry (SPAAC or CuAAC). Carbonyl partners (aldehyde/aminooxy/hydrazide) → oxime/hydrazone ligations.
Below, PEG linkers are organized by Functionality, Reactivity, and Structure to streamline selection and align with common oligonucleotide conjugation workflows.
PEG linkers are typically described by molecular weight, architecture, and reactive functionality:
If you are unsure which PEG architecture or conjugation chemistry best fits your program, our scientists can recommend an optimized format based on modality, placement, and downstream application requirements.
Conjugation chemistry selection should be driven by installed functional handles, buffer and payload compatibility, and the intended stability profile of the final linkage (permanent versus cleavable). Careful chemistry selection minimizes side reactions and supports scalable purification.
Fast and widely used for 5′-amine oligos. Avoid amine buffers (e.g., Tris) during coupling to reduce side reactions.
Bond: amide / carbamate
Highly used for 5′-thiol oligos under mild conditions. Protect thiols from oxidation; control pH for selectivity.
Bond: thioether
Bioorthogonal and copper-free. DBCO can be hydrophobic—PEG length may help solubility and handling.
Bond: triazole
Solubility: hydrophobic handles (DBCO, dyes, lipids) often require longer PEG or branched PEG to prevent precipitation. Biocompatibility: PEG is widely used; in vivo programs may evaluate anti-PEG immune considerations based on use case. Chemical compatibility: NHS esters hydrolyze—use fresh; avoid competing nucleophiles. Thiols oxidize—deprotect/couple promptly. Analytics: dPEG improves mass clarity; polydisperse PEG broadens chromatographic peaks. Performance: excessive PEG shielding may reduce uptake or binding—use the smallest PEG that meets the goal.
Define modality (siRNA/ASO/PNA/PMO), placement (3′/5′/internal), and PEG function (solubility/spacer/shielding).
Select amine/thiol/azide/alkyne or solid-phase PEG reagent based on conjugation chemistry and QC goals.
Execute solid-phase incorporation or post-synthetic coupling under controlled pH/buffer conditions.
Separate conjugated from unconjugated oligo and partial conjugates (method depends on PEG size and modality).
Confirm identity and conjugation completeness via LC-MS and orthogonal chromatographic profiling.
PEGylated oligonucleotides introduce additional critical quality attributes (CQAs), including conjugation completeness, PEG architecture confirmation, linker integrity, and removal of unconjugated or partially conjugated species. Early analytical definition of these attributes supports consistency during scale-up.
Plan for resolution of unconjugated oligo and partial conjugates; dPEG often improves analytical clarity.
LC-MS and orthogonal chromatography support confident assignment of PEGylated product vs impurities.
Assess linker stability and storage/handling windows; especially important for cleavable or thiol-based chemistries.
A PEG linker is a PEG chain with reactive end groups used to covalently attach PEG to an oligonucleotide (3′/5′/internal) and/or to bridge the oligo to another payload.
Use dPEG when you need defined length and clean LC-MS interpretation. Use linear PEG when you need stronger solubility/size effects and broader MW options.
For oligos: NHS–amine (5′-amine), maleimide–thiol (5′-thiol), and SPAAC click (azide–DBCO/BCN) are commonly used for selective coupling.
Choose the site least likely to disrupt function. 3′/5′ are common; internal attachment is useful if termini must remain free or for central spacing.
PEG can sterically block target binding or reduce uptake. Try shortening PEG, switching to a dPEG spacer, or moving PEG to the opposite terminus.
Stable linkers preserve conjugate integrity for distribution/handling studies. Cleavable linkers are used when controlled release is needed; evaluate stability windows and triggers.
Provide your modality (siRNA, ASO, PNA, PMO), intended PEG function (solubility, spacer, shielding, cleavable), preferred placement (3′/5′/internal), and payload requirements. Our team will translate program objectives into a technically and commercially viable PEGylated conjugate strategy.
Representative background reading on nucleic acid therapeutics, chemical conjugation, and delivery barriers.
Additional scientific references are available upon request.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.